Valvulopathies
JESFC 2025

Toujours quelque chose à apprendre autour des valvulopathies

Publié le vendredi 17 janvier 2025

Modérateur(s) :

Laura Munte , Sophie Ribeyrolles

Orateur(s) :

Vincent Doisy , Quentin Landolff , Hysi Ilir , Rahma Trifi , Assia Haddad , Emna Allouche , Varha Isselmou , Houssem Thabet , Omar Azizi , Nourchène Amdouni Moussi

Dans la session

Vincent Doisy First in man use of percutaneous endoclamp in minimally invasive redo mitral surgery, a prospective study
Quentin Landolff Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: a single-centre observational study
Hysi Ilir Axillary Easy-TAVR: feasibility and short-term results
Rahma Trifi Epidemiologic profile of patients with valvular heart disease in tunisia: A hospital-based registry study
Assia Haddad Differences at surgery between patients with bicuspid and tricuspid aortic valves
Emna Allouche Usefulness of electrocardiographic criteria for left ventricular hypertrophy in aortic valve stenosis
Varha Isselmou Prevalence of valvular heart disease in the echocardiography laboratory of the National Cardiology Center of Nouakchott-Mauritania
Houssem Thabet Percutaneous mitral dilatation in men: short term results
Nourchène Amdouni Moussi Immediate Outcomes of Percutaneous Mitral Commissurotomy in Severe Mitral Stenosis: A Single-Center Experience

Partager l'article :